Moxisylyte (Thymoxamine)
An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Also Known As:
Thymoxamine; Acetoxythymoxamine; Arkopharma Brand of Moxisylyte Hydrochloride; Carlytène; Hansam Brand of Moxisylyte Hydrochloride; Icavex; Moxisylyte Hydrochloride; Opilon Brand of Moxisylyte Hydrochloride; Viatris Brand of Moxisylyte Hydrochloride; Hydrochloride, Moxisylyte; Thymoxyalcylamine; Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester)
Networked: 74
relevant articles (5 outcomes,
9 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Laffont, I:
1 article
(02/2001)
|
2. | Dizien, O:
1 article
(02/2001)
|
3. | Boyer, F:
1 article
(02/2001)
|
4. | Lebib Ben Achour, S:
1 article
(02/2001)
|
5. | Boiteau, F:
1 article
(02/2001)
|
6. | Takahashi, H:
1 article
(03/2000)
|
7. | Yamanishi, T:
1 article
(03/2000)
|
8. | Sekita, N:
1 article
(03/2000)
|
9. | Hattori, T:
1 article
(03/2000)
|
10. | Suenaga, T:
1 article
(03/2000)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures